Cardiol Therapeutics (CRDL) Net Cash Flow (2020 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Net Cash Flow came in at $4.4 million in Q1 2026, up 187.95% YoY from $1.5 million in Q1 2025, and down 40.53% on a QoQ basis from $7.4 million in Q4 2025.
Cardiol Therapeutics (CRDL) Net Cash Flow (2020 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 7 years of Net Cash Flow data on file, last reported at $4.4 million in Q1 2026.
- Quarterly Net Cash Flow rose 187.95% year-over-year to $4.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (up 172.93% YoY) and the FY2025 annual result came in at -$6.0 million, down 33.83% from the prior year.
- Net Cash Flow eased to $4.4 million in Q1 2026, from $7.4 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $9.4 million in Q4 2024 to a low of -$9.3 million in Q4 2022.
- A 5-year average of -$2.7 million and a median of -$4.0 million in 2023 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2022 — Net Cash Flow slumped 362.27% — and 2024, when it soared 296.6%.
- Tracing CRDL's Net Cash Flow over 5 years: stood at -$9.3 million in 2022, then soared by 48.68% to -$4.8 million in 2023, then soared by 296.6% to $9.4 million in 2024, then declined by 21.04% to $7.4 million in 2025, then sank by 40.53% to $4.4 million in 2026.
- The last three Net Cash Flow figures came in at $4.4 million (Q1 2026), $7.4 million (Q4 2025), and -$5.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Cardiol Therapeutics | 213.21 Mn | 194.35 Mn | - | -1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.40 Mn |
| Mar 31, 2026 | 4.40 Mn |
| Dec 31, 2025 | 7.40 Mn |
| Dec 31, 2025 | 7.40 Mn |
| Sep 30, 2025 | -5.04 Mn |
| Sep 30, 2025 | -5.04 Mn |
| Jun 30, 2025 | -3.27 Mn |
| Jun 30, 2025 | -3.27 Mn |
| Mar 31, 2025 | -5.00 Mn |
| Mar 31, 2025 | -5.00 Mn |
| Dec 31, 2024 | 9.37 Mn |
| Dec 31, 2024 | 9.37 Mn |
| Sep 30, 2024 | -5.70 Mn |
| Sep 30, 2024 | -5.70 Mn |
| Jun 30, 2024 | -3.44 Mn |
| Jun 30, 2024 | -3.44 Mn |
| Mar 31, 2024 | -5.08 Mn |
| Mar 31, 2024 | -5.08 Mn |
| Dec 31, 2023 | -4.77 Mn |
| Dec 31, 2023 | -4.77 Mn |